Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids

Journal of Clinical Investigation

Volumn 109, Issue 8, 2002, Pages 1041-1048

  Weinstein, Robert S ^a,b   Chen, Jin Ran ^a,b   Powers, Cara C ^a,b   Stewart, Scott A ^a,b   Landes, Reid D ^a,b   Bellido, Teresita ^a,b   Jilka, Robert L ^a,b   Michael Parfitt, A ^a,b   Manolagas, Stavros C ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CASPASE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; PREDNISOLONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE ATROPHY; BONE DENSITY; CELL SURVIVAL; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVATION; LIFESPAN; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; STEM CELL;

EID: 0036123845     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214538     Document Type: Article

References (38)

1. Glucocorticoid-induced osteoporosis
2. Pathogenesis and treatment of steroid osteoporosis
3. Corticosteroid-induced bone loss in men
4. Bone loss in response to long-term glucocorticoid therapy
5. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis
6. A perspective: Bone histomorphometry in glucocorticoid-induced osteoporosis
7. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis
8. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis
9. 3
10. Comparison of trabecular bone architecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis
11. Glucocorticoid-induced osteoporosis
12. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)·1,1·bisphosphonate (APD)
13. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
14. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras
15. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: A prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone
16. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
17. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
18. Apoptosis and osteoporosis
19. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glueocordcoids: Potential mechanisms of the deleterious effects on bone
20. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
21. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
22. Attenuation of the self-renewal of transient-amplifying osteoblast progenitors in the murine bone marrow by 17β estradiol
23. 3 or parathyroid hormone
24. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: Evidence for autonomy from factors released during bone resorption
25. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee
26. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis
27. Unbalanced repeated-measures models with structured covariance matrices
28. Mifepristone (RU 486) - A modulator of progestin and glucocorticoid action
29. Estrogen promotes apoptosis of murine osteo-clasts mediated by TGF-β
30. Comparative study of alendronate vs. etidronate for the treatment of Paget's disease of bone
31. Dose-response relationships for alendronate treatment in osteoporotic elderly women
32. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
33. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro
34. Osteoclast precursors as leukocytes: Importance of the area code
35. Differential effects of glucocorticoid on recruitment and activity of osreoclasts induced by normal and osteocalcin-deficient bone implanted in rats
36. Glucocorticoids stimulate resorption in fetal rat partial bones in vitro